Synonym: 1H-Imidazole (OC-6-11)-tetrachloro(1H-imidazole-κN3)[1,1′-(sulfinyl-κS)bis[methane]]ruthenate(1-) (1:1); ImH[trans-RuCl4(DMSO)Im]; Imidazolium trans-imidazoledimethyl sulfoxide-tetrachlororuthenate
CAS Number: 201653-76-1
Empirical Formula (Hill Notation): C5H10Cl4N2ORuS · C3H5N2
Molecular Weight: 458.18
Linear Formula: C5H10Cl4N2ORuS · C3H5N2
Product Type: Chemical
This picture is provided solely for illustration purposes, it may have been created or edited with AI. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material.
This image depicts SML2090-10MG.
| assay |
≥98% ruthenium (Ru) basis (elemental analysis) |
| color |
faint red to dark brown |
| form |
powder |
| InChI key |
HIAWXYSWERGOAJ-UHFFFAOYSA-K |
| SMILES string |
CS(C)=O.Cl[Ru](Cl)(Cl)Cl.N1=CNC=C1.C2=[NH+]C=CN2 |
| solubility |
H2O: 2 mg/mL, clear |
| storage condition |
desiccated |
| storage temp. |
−20°C |
| Biochem/physiol Actions: |
NAMI-A is a potent antimetastatic drug in vivo that is exhibits little cytotoxicity towards many cancer cell lines. Antimetastatic of NAMI-A is attributed to the formation of adducts with membrane and cytosolic proteins. Nevertheless NAMI-A induces potent and selective cytotoxic effects in several leukemia cell lines. NAMI-A exhibits low toxicity for host tissues. |
| Biochem/physiol Actions: |
NAMI-A is a ruthenium-based anticancer agent. |
| Biochem/physiol Actions: |
potent antimetastatic drug |
| RIDADR |
NONH for all modes of transport |
| WGK Germany |
WGK 3 |
| Flash Point(F) |
Not applicable |
| Flash Point(C) |
Not applicable |
| Purity |
≥98% ruthenium (Ru) basis (elemental analysis) |
| Storage Temp. |
−20°C |
| UNSPSC |
12352200 |